Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,819 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of inflammatory biomarkers in aged patients with oral squamous cell carcinoma.
Yoshimura T, Suzuki H, Takayama H, Higashi S, Hirano Y, Tezuka M, Ishida T, Ishihata K, Amitani M, Amitani H, Nishi Y, Nakamura Y, Imamura Y, Nozoe E, Inui A, Nakamura N. Yoshimura T, et al. Among authors: imamura y. Front Pharmacol. 2022 Nov 21;13:996757. doi: 10.3389/fphar.2022.996757. eCollection 2022. Front Pharmacol. 2022. PMID: 36479205 Free PMC article.
Impact of Preoperative Low Prognostic Nutritional Index and High Intramuscular Adipose Tissue Content on Outcomes of Patients with Oral Squamous Cell Carcinoma.
Yoshimura T, Suzuki H, Takayama H, Higashi S, Hirano Y, Tezuka M, Ishida T, Ishihata K, Nishi Y, Nakamura Y, Imamura Y, Nozoe E, Nakamura N. Yoshimura T, et al. Among authors: imamura y. Cancers (Basel). 2020 Oct 28;12(11):3167. doi: 10.3390/cancers12113167. Cancers (Basel). 2020. PMID: 33126582 Free PMC article.
Prognostic Role of Preoperative Sarcopenia Evaluation of Cervical Muscles with Long-Term Outcomes of Patients with Oral Squamous Cell Carcinoma.
Yoshimura T, Suzuki H, Takayama H, Higashi S, Hirano Y, Tezuka M, Ishida T, Ishihata K, Amitani M, Amitani H, Nishi Y, Nakamura Y, Imamura Y, Nozoe E, Nakamura N. Yoshimura T, et al. Among authors: imamura y. Cancers (Basel). 2021 Sep 21;13(18):4725. doi: 10.3390/cancers13184725. Cancers (Basel). 2021. PMID: 34572952 Free PMC article.
Effect of tolvaptan on the prognosis of patients with hepatic ascites.
Hiramine Y, Uto H, Mawatari S, Kanmura S, Imamura Y, Hiwaki T, Saishoji A, Yada T, Inada Y, Sakamoto H, Higashi H, Kubozono O, Maenohara S, Ido A. Hiramine Y, et al. Among authors: imamura y. Hepatol Res. 2019 Jul;49(7):765-777. doi: 10.1111/hepr.13337. Epub 2019 Apr 30. Hepatol Res. 2019. PMID: 30916842
Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema.
Hiramine Y, Uto H, Imamura Y, Hiwaki T, Kure T, Ijuin S, Oda K, Mawatari S, Kumagai K, Tokunaga K, Higashi H, Kanetsuki I, Kubozono O, Maenohara S, Ido A. Hiramine Y, et al. Among authors: imamura y. Hepatol Res. 2017 May;47(6):542-557. doi: 10.1111/hepr.12778. Epub 2016 Aug 30. Hepatol Res. 2017. PMID: 27448501
1,819 results